Trial of early, goal-directed resuscitation for septic shock.
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Early, goal-directed therapy (EGDT) is recommended in international guidelines for the resuscitation of patients presenting with early septic shock. However, adoption has been limited, and uncertainty about its effectiveness remains. METHODS: We conducted a pragmatic randomized trial with an integrated cost-effectiveness analysis in 56 hospitals in England. Patients were randomly assigned to receive either EGDT (a 6-hour resuscitation protocol) or usual care. The primary clinical outcome was all-cause mortality at 90 days. RESULTS: We enrolled 1260 patients, with 630 assigned to EGDT and 630 to usual care. By 90 days, 184 of 623 patients (29.5%) in the EGDT group and 181 of 620 patients (29.2%) in the usual-care group had died (relative risk in the EGDT group, 1.01; 95% confidence interval [CI], 0.85 to 1.20; P=0.90), for an absolute risk reduction in the EGDT group of -0.3 percentage points (95% CI, -5.4 to 4.7). Increased treatment intensity in the EGDT group was indicated by increased use of intravenous fluids, vasoactive drugs, and red-cell transfusions and reflected by significantly worse organ-failure scores, more days receiving advanced cardiovascular support, and longer stays in the intensive care unit. There were no significant differences in any other secondary outcomes, including health-related quality of life, or in rates of serious adverse events. On average, EGDT increased costs, and the probability that it was cost-effective was below 20%. CONCLUSIONS: In patients with septic shock who were identified early and received intravenous antibiotics and adequate fluid resuscitation, hemodynamic management according to a strict EGDT protocol did not lead to an improvement in outcome. (Funded by the United Kingdom National Institute for Health Research Health Technology Assessment Programme; ProMISe Current Controlled Trials number, ISRCTN36307479.).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the PROCESS (64), ARISE (65) and PROMISE (66) trials, the average volume of fluid received pre-randomization was also in the range of 30 mL/kg, suggesting that this fluid volume has been adopted in routine clinical practice (67).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [66]
In the citing paper
“ProCESS[64], ARISE [65] and ProMISe [66] administered approximately 7–8 L in the usual care groups with a reported low mortality rate.”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [66]
Citations
Cites
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Vincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., & Thijs, L. G. (1996) · Intensive Care Medicine · doi:10.1007/bf01709751 · Cited by 11,674 · cited 10×
“6) EM (7)/CCM (2)/AM (2) Royal Preston Hospital Non-teaching June 2011 - July 2014 708 74852 22 10 ED (4)/CCU (8)/Ward (1) 9 (90.”
BackgroundInfluentialEarly goal-directed therapy in the treatment of severe sepsis and septic shock
Rivers, E., Nguyen, B., Havstad, S., Ressler, J., Muzzin, A., Knoblich, B., Peterson, E., & Tomlanovich, M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010307 · Cited by 10,743 · cited 3×
“Moderate problems 83 (24) 82 (25) Severe problems 62 (18) 51 (15) Extreme problems 52 (15) 50 (15) Pain/Discomfort”
BackgroundSurviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
Self-citationThe Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup*, Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,290
Self-citationDellinger, R. P., Levy, M. M., Carlet, J. M., Bion, J., Parker, M. M., Jaeschke, R., Reinhart, K., Angus, D. C., Brun-Buisson, C., Beale, R., et al. (2008) · Intensive Care Medicine · doi:10.1007/s00134-007-0934-2 · Cited by 6,772
Self-citationSurviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
Dellinger, R. P., Carlet, J. M., Masur, H., Gerlach, H., Calandra, T., Cohen, J., Gea-Banacloche, J., Keh, D., Marshall, J. C., Parker, M. M., et al. (2004) · Intensive Care Medicine · doi:10.1007/s00134-004-2210-z · Cited by 3,321
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
Dellinger, R. P., Carlet, J. M., Masur, H., Gerlach, H., Calandra, T., Cohen, J., Gea-Banacloche, J., Keh, D., Marshall, J. C., Parker, M. M., et al. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000117317.18092.e4 · Cited by 3,018
A randomized trial of protocol-based care for early septic shock.
The ProCESS Investigators (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1401602 · Cited by 2,414 · cited 2×
“Royal Berkshire Hospital Non-teaching August 2011 - July 2014 660 100000 55 27 ED (22)/CCU (26)/Ward (1) 26 (96.”
BackgroundGoal-Directed Resuscitation for Patients with Early Septic Shock
The ARISE Investigators and the ANZICS Clinical Trials Group (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1404380 · Cited by 2,028
Research works printed but not linked: 1
- Power GS, 2013, Crit Care Resusc, 15, 311
Cited by
Items 201–300 of 1,000
Recent advances in bedside microcirculation assessment in critically ill patients
Tafner, P. F. D. A., Chen, F. K., Filho, R. R., Corrêa, T. D., Chaves, R. C. D. F., & Neto, A. S. (2017) · Revista Brasileira de Terapia Intensiva · doi:10.5935/0103-507x.20170033 · Cited by 62
“Parameters related to macrocirculation, such as the mean arterial pressure (MAP), central venous pressure (CVP), cardiac output (CO), mixed venous saturation (SvO2) and central venous oxygen saturation (ScvO2), are commonly used in the hemodynamic assessment of critically ill patients.(1-4) However, several studies ha…”
BackgroundHirsch, K. G., Abella, B. S., Amorim, E., Bader, M. K., Barletta, J. F., Berg, K. M., Callaway, C. W., Friberg, H., Gilmore, E. J., Greer, D. M., et al. (2023) · Neurocritical Care · doi:10.1007/s12028-023-01871-6 · Cited by 78
Sartelli, M., Tascini, C., Coccolini, F., Dellai, F., Ansaloni, L., Antonelli, M. M., Bartoletti, M., Bassetti, M., Boncagni, F., Carlini, M., et al. (2024) · World Journal of Emergency Surgery · doi:10.1186/s13017-024-00551-w · Cited by 77
Reasons for death in patients with sepsis and septic shock
Moskowitz, A. L., Omar, Y. G., Chase, M., Lokhandwala, S., Patel, P., Andersen, L. W., Cocchi, M. N., & Donnino, M. W. (2016) · Journal of Critical Care · doi:10.1016/j.jcrc.2016.11.036 · Cited by 62
“[15] The 3 recently completed large trials of early goal-directed resuscitation for septic shock chose all-causemortality as an end point and do not report on the specific reason for death in those who died [16-18].”
Management of Sepsis in Patients With Cirrhosis: Current Evidence and Practical Approach
Simonetto, D. A., Serafim, L. P., de Moraes, A. G., Gajic, O., & Kamath, P. S. (2018) · Hepatology · doi:10.1002/hep.30412 · Cited by 64
“422 of EGDT and physiological parameters, such as urine output, lactate clearance, and administration of antibiotics, within 1 hour of presentation.(20,22,23) It is important to highlight that all the aforementioned parameters are often abnormal at baseline in patients with cirrhosis, and the optimal endpoints for res…”
BackgroundSepsis With Preexisting Heart Failure: Management of Confounding Clinical Features
Jones, T. W., Smith, S. E., Tuyl, J. S. V., & Sikora, A. N. (2020) · Journal of Intensive Care Medicine · doi:10.1177/0885066620928299 · Cited by 72
Reyner, K., Heffner, A. C., & Karvetski, C. (2015) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2015.12.068 · Cited by 61
“Infections of the urinary tract (UTIs) account for approximately 20% of severe sepsis cases [3,4].”
BackgroundThe long-term burden of severe sepsis and septic shock
Guirgis, F. W., Brakenridge, S. C., Sutchu, S., Khadpe, J. D., Robinson, T. J., Westenbarger, R., Topp, S. T., Kalynych, C. J., Reynolds, J. A., Dodani, S., et al. (2016) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000001135 · Cited by 61
Cost-Effectiveness Studies in the ICU: A Systematic Review*
Wilcox, M. E., Vaughan, K., Chong, C. A. K. Y., Neumann, P. J., & Bell, C. M. (2019) · Critical Care Medicine · doi:10.1097/ccm.0000000000003768 · Cited by 65
Characteristics and outcomes of patients with community-acquired and hospital-acquired sepsis
Westphal, G. A., Pereira, A. B., Fachin, S. M., Barreto, A. C. C., Bornschein, A. C. G. J., Filho, M. C., & Köenig, Á. (2019) · Revista Brasileira de Terapia Intensiva · doi:10.5935/0103-507x.20190013 · Cited by 93
“After initial assessment by the nurse, the medical team was notified to evaluate the patient, to confirm the diagnosis of sepsis, to look for other organ dysfunctions not evaluated in the screening protocol and to initiate treatment.(5,7,9-15) The diagnosis of sepsis (formerly called severe sepsis) was defined in the…”
BackgroundMethodOgbu, O. C., Murphy, D. J., & Martin, G. S. (2015) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000211 · Cited by 69
Semler, M. W., & Rice, T. W. (2016) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2016.01.007 · Cited by 67
Shock subtypes by left ventricular ejection fraction following out-of-hospital cardiac arrest
Anderson, R. J., Jinadasa, S. P., Hsu, L., Ghafouri, T. B., Tyagi, S. K., Joshua, J., Mueller, A., Talmor, D. S., Sell, R., & Beitler, J. R. (2018) · Critical Care · doi:10.1186/s13054-018-2078-x · Cited by 62
Sepsis, Management & Advances in Metabolomics
Pandey, S. (2024) · Nanotheranostics · doi:10.7150/ntno.94071 · Cited by 65
“…of Protocol-based Cre for Early Septic Shock), ProMISE (Protocoloized Managemen in Sepsis), and ARISE (The Australasian Resuscitation In Sepsis Evaluation) [53, 54] Various studies emphasized macrocirculatory resuscitation; however, studies on microcirculatory resuscitation need to be performed.”
Dagher, G. A., Khuri, C. E., Chehadeh, A. A.-H., Chami, A., Bachir, R. H., Zebian, D., & Chebl, R. B. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-013502 · Cited by 59
Balamuth, F., Kittick, M., McBride, P., Woodford, A. L., Vestal, N. L., Casper, T. C., Metheney, M., Smith, K. A., Atkin, N. J., Baren, J. M., et al. (2019) · Academic Emergency Medicine · doi:10.1111/acem.13815 · Cited by 64
Impact on patient outcome of emergency department length of stay prior to ICU admission
García-Gigorro, R., Vigó, F. D. L. C., Andres, E. M., Chacón-Alves, S., Varas, G. M., Sánchez‐Izquierdo, J. Á., & González, J. C. M. (2016) · Medicina Intensiva · doi:10.1016/j.medin.2016.05.008 · Cited by 66
“0 0 20 40 60 Median of hospital length of stay: 15 days (9-26) P<.”
BackgroundSzakmány, T., Pugh, R. J., Kopczynska, M., Lundin, R. M., Sharif, B., Morgan, P., Ellis, G., Abreu, J., Kulikouskaya, S., Bashir, K., et al. (2017) · Anaesthesia · doi:10.1111/anae.14062 · Cited by 71
“On the other hand, the recent PROMISE trial in the UK, that recruited patients with severe sepsis and septic shock according to the SEP-SIS-1 de fi nition, reported 24.5% mortality at 28 days in the control arm, where patient characteristics were similar to our study [29].”
ResultInfluentialMurray, E. J., Caniglia, E. C., Swanson, S. A., Hernández–Díaz, S., & Hernán, M. Á. (2018) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2018.06.009 · Cited by 62
Sepsis Bundle Adherence Is Associated with Improved Survival in Severe Sepsis or Septic Shock
Milano, P., Desai, S., Eiting, E., Hofmann, E., Lam, C. N., & Menchine, M. D. (1996) · Western Journal of Emergency Medicine · doi:10.5811/westjem.2018.7.37651 · Cited by 60
Dubin, A., Lattanzio, B., & Gatti, L. (2017) · Revista Brasileira de Terapia Intensiva · doi:10.5935/0103-507x.20170068 · Cited by 56
“In three large, randomized controlled trials in which dobutamine was used as part of the EGDT, no side effects related to dobutamine were reported.(36-38) Nevertheless, the higher requirements for vasopressors in the EGDT group compared to the control group might reflect dobutamine-induced vasodilation.”
BackgroundSzakmány, T., Lundin, R. M., Sharif, B., Ellis, G., Morgan, P., Kopczynska, M., Dhadda, A., Mann, C., Donoghue, D., Rollason, S., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167230 · Cited by 58
Zhou, X. Q., Liu, D., Su, L., Yao, B., Long, Y., Wang, X., Chai, W., Cui, N., Wang, H., & Xi, R. (2017) · Critical Care · doi:10.1186/s13054-017-1617-1 · Cited by 63
Stroke volume guided resuscitation in severe sepsis and septic shock improves outcomes
Latham, H. E., Bengtson, C. D., Satterwhite, L. G., Stites, M., Subramaniam, D. P., Chen, G. J., & Simpson, S. Q. (2017) · Journal of Critical Care · doi:10.1016/j.jcrc.2017.06.028 · Cited by 57
Antimicrobial Treatment Duration in Sepsis and Serious Infections
Busch, L. M., & Kadri, S. S. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa247 · Cited by 63
Casey, J. D., Brown, R. M., & Semler, M. W. (2018) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000551 · Cited by 74
Early goal-directed therapy for severe sepsis and septic shock: A living systematic review
Simpson, S. Q., Gaines, M., Hussein, Y., & Badgett, R. G. (2016) · Journal of Critical Care · doi:10.1016/j.jcrc.2016.06.017 · Cited by 55
Trends in mortality in septic patients according to the different organ failure during 15 years
Cárdenas, C. L., Yébenes, J. C., Vela, E., Clèries, M., Sirvent, J. M., Bertolin, C., Reina, C., Rodríguez, A. H., Ruiz‐Rodríguez, J. C., Trenado, J., et al. (2022) · Critical Care · doi:10.1186/s13054-022-04176-w · Cited by 77
Khanna, A. K., Kinoshita, T., Natarajan, A., Schwager, E., Linn, D. D., Dong, J., Ghosh, E., Vicario, F., & Maheshwari, K. K. (2023) · Annals of Intensive Care · doi:10.1186/s13613-023-01101-4 · Cited by 70
Kuan, W. S., Ibrahim, I., Leong, B. S., Jain, S., Lu, Q., Cheung, Y. B., & Mahadevan, M. (2015) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2015.09.010 · Cited by 56
Risk Factors for Urosepsis in Older Adults: A Systematic Review
Peach, B. C., Garvan, G. J., Garvan, C. S., & Cimiotti, J. P. (2016) · Gerontology and Geriatric Medicine · doi:10.1177/2333721416638980 · Cited by 59
“The more recent PROCESS (ProCESS Investigators et al., 2014), ARISE (Peake et al., 2014), and PROMISE (Mouncey et al., 2015) trials found results that will no doubt lead to changes in the current management of urosepsis.”
ResultThiessen, S., den Berghe, G. V., & Vanhorebeek, I. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.02.015 · Cited by 57
Hellman, J., Bahrami, S., Boros, M., Chaudry, I. H., Fritsch, G., Goździk, W., Inoue, S., Radermacher, P., Singer, M., Osuchowski, M. F., et al. (2018) · Shock · doi:10.1097/shk.0000000000001209 · Cited by 66
“recommended the above static variables for the monitoring of fluid administration during sepsis (68), however their findings were not subsequently confirmed by several multicenter clinical trials (4-6).”
BackgroundInfluentialSelf-citationSepsis: An Update on Current Practices in Diagnosis and Management
Jain, S. (2018) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2018.06.012 · Cited by 63
Update in sepsis guidelines: what is really new?
Plevin, R. E., & Callcut, R. A. (2017) · Trauma Surgery & Acute Care Open · doi:10.1136/tsaco-2017-000088 · Cited by 57
“11 The movement away from a prescribed static variables such as CVP and ScVO2 as a goal reflects the results of three recent clinical trials (PROMISE, 19 ARISE, 20 PROCESS 21 ) that called in to question the utility and benefit of EGDT including the need for a mandatory central line.”
The Urosepsis—A Literature Review
Guliciuc, M., Maier, A. C., Maier, I. M., Kraft, A., Cucuruzac, R., Marinescu, M., Șerban, C., Rebegea, L. F., Constantin, G. B., & Firescu, D. (2021) · Medicina · doi:10.3390/medicina57090872 · Cited by 67
Jo, S., Jeong, T., Lee, J. B., Jin, Y., Yoon, J. C., & Park, B. (2015) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2015.12.067 · Cited by 59
Ma, P., Liu, J., Shen, F., Liao, X., Xiu, M., Zhao, H., Zhao, M., Xie, J., Wang, P., Huang, M., et al. (2021) · Critical Care · doi:10.1186/s13054-021-03682-7 · Cited by 61
“Since sepsis and/or septic shock is a heterogeneous clinical syndrome, many clinical trials targeting sepsis population usually result in neutral findings [2, 10, 11].”
BackgroundHemodynamic Monitoring in Sepsis—A Conceptual Framework of Macro- and Microcirculatory Alterations
Văleanu, L., Bubenek-Turconi, Ş.-I., Ginghină, C., & Balan, C. I. (2021) · Diagnostics · doi:10.3390/diagnostics11091559 · Cited by 60
Management of Sepsis and Septic Shock: What Have We Learned in the Last Two Decades?
Kamath, S., Altaq, H. H., & Abdo, T. (2023) · Microorganisms · doi:10.3390/microorganisms11092231 · Cited by 69
“As the average volume of fl uid pre-randomization was approximately 30 mL/kg in these three trials, the SSC guidelines “strongly” recommended at least 30 mL/kg of IV crystalloid fl uid be given within the fi rst 3 hours, despite “low-quality evidence” of a bene fi t [29–31,33].”
InfluentialMebazaa, A., Laterre, P., Russell, J. A., Bergmann, A., Gattinoni, L., Gayat, É., Harhay, M. O., Hartmann, O., Hein, F., Kjølbye, A. L., et al. (2016) · Journal of Intensive Care · doi:10.1186/s40560-016-0151-6 · Cited by 61
“(ProMISE) [31], similar to previous over-estimates in”
MethodArabi, Y. M., Al-Dorzi, H. M., Alamry, A., Hijazi, R., Alsolamy, S., Al Salamah, M., Tamim, H. M., Al-Qahtani, S., Al-Dawood, A., Marini, A. M., et al. (2017) · Annals of Intensive Care · doi:10.1186/s13613-017-0280-7 · Cited by 52
Controversies in Corticosteroid use for Sepsis
Long, B., & Koyfman, A. (2017) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2017.05.024 · Cited by 53
Long-Term β-Blocker Therapy Decreases Blood Lactate Concentration in Severely Septic Patients*
Contenti, J., Occelli, C., Corraze, H., Lemoël, F., & Levraut, J. (2015) · Critical Care Medicine · doi:10.1097/ccm.0000000000001308 · Cited by 57
“Mechanical ventilation, n (%) 10 (15) 38 (19) 0.”
For the Canadian Critical Care Trials Group and the Canadian Critical Care Translational Biology Group, Parker, M. J., Thabane, L., Fox‐Robichaud, A., Liaw, P. C., & Choong, K. L. M. (2016) · Trials · doi:10.1186/s13063-016-1689-2 · Cited by 54
Roberts, N., Hooper, G., Lorencatto, F., Storr, W., & Spivey, M. (2017) · Scandinavian Journal of Trauma Resuscitation and Emergency Medicine · doi:10.1186/s13049-017-0437-2 · Cited by 68
Hu, B., Chen, J. C. Y., Dong, Y., Frank, R. D., Passe, M. A., Portner, E. R., Peng, Z., & KASHANI, K. B. (2020) · Critical Care · doi:10.1186/s13054-020-2819-5 · Cited by 56
“Also, three recent multi-center randomized controlled trials [13] [14] [15] and a follow-up metaanalysis [16] showed that early goal-directed therapy (EGDT) bundles in comparison with usual care were not associated with improved outcomes in septic shock.”
BackgroundEffect of Early Balanced Crystalloids Before ICU Admission on Sepsis Outcomes
Jackson, K. E., Wang, L., Casey, J. D., Bernard, G. R., Self, W. H., Rice, T. W., & Semler, M. W. (2020) · CHEST Journal · doi:10.1016/j.chest.2020.08.2068 · Cited by 55
Chelkeba, L., Ahmadi, A., Abdollahi, M., Najafi, A., Ghadimi, M. H., Mosaed, R., & Mojtahedzadeh, M. (2015) · Annals of Intensive Care · doi:10.1186/s13613-015-0071-y · Cited by 51
“60 13/19 3/35 46 [8–259] <0.”
MethodResultRussell, A., Rivers, E. P., Giri, P. C., Jaehne, A. K., & Nguyen, H. B. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9072052 · Cited by 56
Peripherally administered orexin improves survival of mice with endotoxin shock
Ogawa, Y., Irukayama‐Tomobe, Y., Murakoshi, N., Kiyama, M., Ishikawa, Y., Hosokawa, N., Tominaga, H., Uchida, S., Kimura, S., Kanuka, M., et al. (2016) · eLife · doi:10.7554/elife.21055 · Cited by 55
Kellum, J. A., Pike, F., Yealy, D. M., Huang, D. T., Shapiro, N. I., & Angus, D. C. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002206 · Cited by 51
Gelman, S., & Bigatello, L. M. (2017) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-017-1045-3 · Cited by 52
A Quality Improvement Collaborative for Pediatric Sepsis: Lessons Learned
Paul, R. M., Melendez, E., Wathen, B., Larsen, G. Y., Chapman, L., Wheeler, D. S., Wakefield, T., & Macias, C. G. (2018) · Pediatric Quality and Safety · doi:10.1097/pq9.0000000000000051 · Cited by 53
Siew, E. D., Basu, R. K., Wunsch, H., Shaw, A., Goldstein, S. L., Ronco, C., Kellum, J. A., Bagshaw, S. M., & on behalf of the 15th ADQI Consensus Group (2016) · Canadian Journal of Kidney Health and Disease · doi:10.1186/s40697-016-0098-5 · Cited by 52
Leisman, D. E., Huang, V., Zhou, Q., Gribben, J. L., Bianculli, A. R., Bernshteyn, M., Ward, M. F., & Schneider, S. M. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002377 · Cited by 56
Prevention and Therapy of Acute Kidney Injury in the Developing World
Kher, V., Srisawat, N., Noiri, E., Gharbi, M. B., Shetty, M. S., Yang, L., Bagga, A., Chakravarthi, R. M., & Mehta, R. L. (2017) · Kidney International Reports · doi:10.1016/j.ekir.2017.03.015 · Cited by 61
Lankadeva, Y. R., Kosaka, J., Iguchi, N., Evans, R. G., Booth, L. C., Bellomo, R., & May, C. N. (2018) · Critical Care Medicine · doi:10.1097/ccm.0000000000003507 · Cited by 52
Li, L., Jin, T., Wen, S., Shi, N., Zhang, R., Zhu, P., Lin, Z., Jiang, K., Guo, J., Liu, T., et al. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-05985-w · Cited by 55
Deciphering the epidemiology of invasive candidiasis in the intensive care unit: is it possible?
Soulountsi, V., Schizodimos, T., & Kotoulas, S. (2021) · Infection · doi:10.1007/s15010-021-01640-7 · Cited by 59
Suberviola, B., Rodrigo, E., González-Castro, A., Serrano, M., Heras, M., & Castellanos-Ortega, Á. (2016) · Medicina Intensiva · doi:10.1016/j.medin.2016.07.010 · Cited by 49
Lesur, O., Delile, E., Asfar, P., & Radermacher, P. (2018) · Annals of Intensive Care · doi:10.1186/s13613-018-0449-8 · Cited by 56
Temporal trends in the utilization of vasopressors in intensive care units: an epidemiologic study
Thongprayoon, C., Cheungpasitporn, W., Harrison, A. M., Carrera, P., Srivali, N., Kittamongkolchai, W., Erdoğan, A., & KASHANI, K. B. (2016) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-016-0063-z · Cited by 54
“The future use of vasopressors in ICUs may change as a result of recent randomized controlled trials conducted by ProCESS investigators [39] from the United States and ARISE investigators from Australia & New Zealand [40, 41].”
BackgroundCardiac Function and Dysfunction in Sepsis
Fenton, K. E., & Parker, M. M. (2016) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2016.01.014 · Cited by 49
Ciaffoni, L., O'Neill, D., Couper, J. H., Ritchie, G. A. D., Hancock, G., & Robbins, P. A. (2016) · Science Advances · doi:10.1126/sciadv.1600560 · Cited by 53
Best practice in critical care: anaemia in acute and critical illness
Docherty, A. B., Turgeon, A. F., & Walsh, T. S. (2018) · Transfusion Medicine · doi:10.1111/tme.12505 · Cited by 53
“More recently, however, three large international multicentre trials [PROMISE (Mouncey et al., 2015), ARISE (ARISE Investigators et al.”
BackgroundPediatric Acute Respiratory Distress Syndrome: Fluid Management in the PICU
Ingelse, S. A., Asperen, R. M. W., Lemson, J., Daams, J. G., Reinout, A., & van Woensel, J. B. M. (2016) · Frontiers in Pediatrics · doi:10.3389/fped.2016.00021 · Cited by 50
“This appears in line with the current adult literature on sepsis, which suggests that although early goal-directed therapy including (aggressive) fluid resuscitation is generally beneficial, it does not always lead to reduced mortality (9–11), and may even be associated with longer hospitalization and higher organ fai…”
ResultEmpfehlungen zum hämodynamischen Monitoring in der internistischen Intensivmedizin
Janssens, U., Jung, C., Hennersdorf, M., Ferrari, M. W., Fuhrmann, J. T., Buerke, M., Ebelt, H., Graf, T., Thiele, H., Kelm, M., et al. (2016) · Der Kardiologe · doi:10.1007/s12181-016-0060-x · Cited by 50
A Users’ Guide to the 2016 Surviving Sepsis Guidelines
Dellinger, R. P., Schorr, C., & Levy, M. M. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002257 · Cited by 48
Pulmonary Consequences of Acute Kidney Injury
Teixeira, J. P., Ambruso, S. L., Griffin, B. R., & Faubel, S. G. (2018) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2018.10.001 · Cited by 55
Acute Respiratory Distress Syndrome
Yang, P., Kim, P., & Martin, G. S. (2024) · Springer eBooks · doi:10.1007/978-3-032-22660-0_13 · Cited by 51
Meng, J., Hu, M., Lai, Z.-Z., Ji, C., Xu, X., Zhang, G., & Tian, S. (2016) · Medical Science Monitor · doi:10.12659/msm.898457 · Cited by 50
“suggested in 2001 that early goal-directed therapy (EGDT) was effective for severe sepsis management [6], however, several recent studies, including the ProCESS [7] and ARISE [8] trials in 2014 and the ProMiSe trial [9] in 2015 indicated that EGDT did not improve outcomes compared to usual care.”
ResultYang, X., Tu, G.-W., Zheng, J., Shen, B., Ma, G., Hao, G., Gao, J., & Luo, Z. (2017) · BMC Nephrology · doi:10.1186/s12882-017-0667-6 · Cited by 47
The macro- and microcirculation of the kidney
Guerci, P., Ergin, B., & İnce, C. (2017) · Best practice & research. Clinical anaesthesiology · doi:10.1016/j.bpa.2017.10.002 · Cited by 58
Maternal sepsis update: current management and controversies
Greer, O., Shah, N. M., & Johnson, M. R. (2019) · The Obstetrician & Gynaecologist · doi:10.1111/tog.12623 · Cited by 51
de Grahl, C., Hartwig, T., Weidhase, L., Laudi, S., Petros, S., Gries, A., & Bernhard, M. (2021) · Die Anaesthesiologie · doi:10.1007/s00101-021-00962-3 · Cited by 53
Seethala, R. R., Hou, P. C., Aisiku, I. P., Frendl, G., Park, P. K., Mikkelsen, M. E., Chang, S. Y., Gajic, O., & Sevransky, J. (2017) · Annals of Intensive Care · doi:10.1186/s13613-017-0233-1 · Cited by 51
Strandberg, G., Walther, S., Öhman, C. A., & Lipcsey, M. (2020) · Acta Anaesthesiologica Scandinavica · doi:10.1111/aas.13587 · Cited by 54
Weiss, S. L., Peters, M. J., Oczkowski, S. J. W., Belley‐Côté, E. P., Buysse, C., Choong, K. L. M., Deep, A., Inwald, D. P., Flori, H. R., Kneyber, M. C. J., et al. (2026) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0000000000003927 · Cited by 58
Defining the characteristics and expectations of fluid bolus therapy: A worldwide perspective
Glassford, N. J., Mårtensson, J., Eastwood, G. M., Jones, S. L., Tanaka, A., Wilkman, E., Bailey, M., Bellomo, R., Arabi, Y. M., Bagshaw, S. M., et al. (2016) · Journal of Critical Care · doi:10.1016/j.jcrc.2016.05.017 · Cited by 47
Wittayachamnankul, B., Chentanakij, B., Sruamsiri, K., & Chattipakorn, N. (2016) · Journal of Critical Care · doi:10.1016/j.jcrc.2016.08.002 · Cited by 46
Mosier, J. M., Stolz, U., Milligan, R., Roy-Chaudhury, A., Lutrick, K., Hypes, C. D., Billheimer, D. D., & Cairns, C. B. (2019) · Critical Care Explorations · doi:10.1097/cce.0000000000000019 · Cited by 50
Development and Implementation of Sepsis Alert Systems
Harrison, A. M., Gajic, O., Pickering, B. W., & Herasevich, V. (2016) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2016.01.004 · Cited by 46
Kim, H., Chung, S. P., Choi, S.-H., Kang, G. H., Shin, T. G., Kim, K., Park, Y. S., Han, K. S., Choi, H. S., Suh, G. J., et al. (2019) · Journal of Critical Care · doi:10.1016/j.jcrc.2019.06.012 · Cited by 45
Fluid Therapy in Dogs and Cats With Sepsis
Montealegre, F., & Lyons, B. (2021) · Frontiers in Veterinary Science · doi:10.3389/fvets.2021.622127 · Cited by 51
Chow, J. H., Abuelkasem, E., Sankova, S. K., Henderson, R. A., Mazzeffi, M. A., & Tanaka, K. A. (2019) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000004343 · Cited by 48
Weiss, S. L., Peters, M. J., Oczkowski, S. J. W., Belley‐Côté, E. P., Buysse, C., Choong, K. L. M., Deep, A., Inwald, D. P., Flori, H. R., Kneyber, M. C. J., et al. (2026) · Intensive Care Medicine · doi:10.1007/s00134-026-08360-2 · Cited by 53
“However, more recent studies of EGDT in adults failed to demonstrate a reduction in mortality compared with standardized treat-ment protocols that did not mandate Scvo 2 monitoring in three subsequent RCTs [101–103].”
Fluid Resuscitation in Severe Sepsis
Loflin, R., & Winters, M. E. (2016) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2016.08.001 · Cited by 47
Estimating attributable fraction of mortality from sepsis to inform clinical trials
Shankar‐Hari, M., Harrison, D. A., Rowan, K., & Rubenfeld, G. D. (2018) · Journal of Critical Care · doi:10.1016/j.jcrc.2018.01.018 · Cited by 49
“Numerous sepsis randomized clinical trials (RCTs) that do not demonstrate a statistically significant difference in the primary end point [3] may be explained by treatment response variations seen within trial populations [4-7] and differences in sepsis pathobiology [3, 8].”
BackgroundSelf-citationSamsudin, M. I., Liu, N., Prabhakar, S. M., Chong, S., Lye, W. K., Koh, Z. X., Guo, D., Rajesh, R., Ho, A. F. W., & Ong, M. E. H. (2018) · Medicine · doi:10.1097/md.0000000000010866 · Cited by 50
Musikatavorn, K., Plitawanon, P., Lumlertgul, S., Narajeenron, K., Rojanasarntikul, D., Tarapan, T., & Saoraya, J. (2021) · Western Journal of Emergency Medicine · doi:10.5811/westjem.2020.11.48571 · Cited by 49
“Length of stay (days), median (IQR)a 8(5-16) 8(5-16.”
BackgroundThe Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024
Shime, N., Nakada, T.-A., Yatabe, T., Yamakawa, K., Aoki, Y., Inoue, S., Iba, T., Ogura, H., Kawai, Y., Kawaguchi, A., et al. (2025) · Journal of Intensive Care · doi:10.1186/s40560-025-00776-0 · Cited by 52
Anemia and Red Blood Cell Transfusion
Napolitano, L. M. (2017) · Critical Care Clinics · doi:10.1016/j.ccc.2016.12.011 · Cited by 48
Korean Shock Society septic shock registry: a preliminary report
Shin, T. G., Hwang, S. Y., Kang, G. H., Kim, W. Y., Ryoo, S. M., Kim, K., Jo, Y. H., Chung, S. P., Joo, Y. S., Beom, J. H., et al. (2017) · Clinical and Experimental Emergency Medicine · doi:10.15441/ceem.17.204 · Cited by 43
“6% 28-day mortality.(8,10) Our study, with similar inclusion criteria to these trials, showed comparable mortality rates.”
ResultAcute Pancreatitis: Etiology, Pathology, Diagnosis, and Treatment
Majidi, S., Golembioski, A., Wilson, S. L., & Thompson, E. C. (2017) · Southern Medical Journal · doi:10.14423/smj.0000000000000727 · Cited by 49
“As a result of the goal-directed article, there have been several well-designed randomized prospective multicenter trials that have shown no benefit to using goal-directed therapy.(28,29) These newer studies have refuted the notion that specific goals such as a central venous pressure >8 and/or oxygen saturation >70%…”
BackgroundBitton, E., Zimmerman, S. F., Azevedo, L. C. P., Benhamou, D., Cecconi, M., Waele, J. J. D., Lipman, J., Martín‐Loeches, I., Pirracchio, R., Scheeren, T., et al. (2021) · Journal of Critical Care · doi:10.1016/j.jcrc.2021.11.016 · Cited by 45
McDonnell, C. J., Garciarena, C. D., Watkin, R., McHale, T. M., McLoughlin, A., Claes, J., Verhamme, P. B., Cummins, P. M., & Kerrigan, S. W. (2016) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13501 · Cited by 52
Physiology of Human Hemorrhage and Compensation
Convertino, V. A., Koons, N. J., & Suresh, M. R. (2021) · Wiley eBooks · doi:10.1002/cphy.c200016 · Cited by 47
Time to antibiotics and the outcome of patients with septic shock: A propensity score analysis.
Ko, B. S., Choi, S.-H., Kang, G. H., Shin, T. G., Kim, K., Jo, Y. H., Ryoo, S. M., Kim, Y.-J., Park, Y. S., Kwon, W. Y., et al. (2020) · The American Journal of Medicine · doi:10.1016/j.amjmed.2019.09.012 · Cited by 42
Karakike, E., Scicluna, B. P., Roumpoutsou, M., Mitrou, I., Karampela, N., Karageorgos, A., Psaroulis, K., Massa, E., Pitsoulis, A., Chaloulis, P., et al. (2022) · Critical Care · doi:10.1186/s13054-022-04055-4 · Cited by 44
“Despite early recognition, timely antimicrobial administration and organ support, further adjunctive therapies are required [4].”
Background
Metadata
- Authors
- Mouncey, P. R., Osborn, T. M., Power, G. S., Harrison, D. A., Sadique, M. Z., Grieve, R. D., Jahan, R., Harvey, S. E., Bell, D., Bion, J. F., Coats, T. J., Singer, M., Young, J. D., & Rowan, K. M.
- Affiliations
- University of Leicester (GB)
- Washington University in St. Louis (US)
- Intensive Care National Audit & Research Centre (GB)
- London School of Hygiene & Tropical Medicine (GB)
- Chelsea and Westminster Hospital NHS Foundation Trust (GB)
- University of Birmingham (GB)
- University College London (GB)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2015-04-02
- Volume
- 372
- Issue
- 14
- Pages
- 1301-1311
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2098019283
- Cited by
- 1,604
- References
- 29
- Citations by year
- 2026: 68 · 2025: 65 · 2024: 88 · 2023: 100 · 2022: 104 · 2021: 136 · 2020: 148 · 2019: 145 · 2018: 146 · 2017: 213 · 2016: 255 · 2015: 128
- FWCI
- 194.51
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Digital Commons@Becker (Washington University School of Medicine) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Leicester Research Archive (University of Leicester) (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion, other-oa)
- Funders
- National Institute for Health and Care Research (SRF-2013-06-016, 07/37/47)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Surgery › Hemodynamic Monitoring and Therapy
- Health Sciences › Medicine › Surgery › Abdominal Surgery and Complications
- Keywords
- early goal-directed therapy, septic shock, fluid resuscitation, 90-day mortality, cost-effectiveness, hemodynamic management, vasoactive drugs, red blood cell transfusion, organ failure, ICU length of stay, health-related quality of life, adverse events
- MeSH terms
- Adult, Aged, Anti-Bacterial Agents, Blood Transfusion, Clinical Protocols, Combined Modality Therapy, Cost-Benefit Analysis, Female, Fluid Therapy, Humans, Infusions, Intravenous, Male, Middle Aged, Quality of Life, Resuscitation, Shock, Septic, Vasoconstrictor Agents, Practice Guidelines as Topic, Quality-Adjusted Life Years, Kaplan-Meier Estimate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.